Chembio Diagnostics, Inc. (CEMI): Price and Financial Metrics
Chembio Diagnostics, Inc. (CEMI)
Today's Latest Price: $6.45 USD
Updated Jan 25 3:25pm
Add CEMI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 64 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
CEMI Stock Summary
- In terms of twelve month growth in earnings before interest and taxes, Chembio Diagnostics Inc is reporting a growth rate of 50.56%; that's higher than 81.55% of US stocks.
- The volatility of Chembio Diagnostics Inc's share price is greater than that of 91.67% US stocks with at least 200 days of trading history.
- Chembio Diagnostics Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -22.15%, greater than the shareholder yield of just 11.76% of stocks in our set.
- Stocks that are quantitatively similar to CEMI, based on their financial statements, market capitalization, and price volatility, are VJET, SANW, AMOT, MDRX, and HTGM.
- Visit CEMI's SEC page to see the company's official filings. To visit the company's web site, go to chembio.com.
CEMI Stock Price Chart Interactive Chart >
CEMI Price/Volume Stats
| Current price | $6.45 | 52-week high | $15.89 |
| Prev. close | $6.31 | 52-week low | $2.25 |
| Day low | $6.01 | Volume | 760,302 |
| Day high | $6.53 | Avg. volume | 1,109,873 |
| 50-day MA | $5.51 | Dividend yield | N/A |
| 200-day MA | $6.37 | Market Cap | 130.14M |
Chembio Diagnostics, Inc. (CEMI) Company Bio
Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care (POC) diagnostic tests that detect infectious diseases. The company was founded in 1985 and is based in Medford, New York.
Loading social stream, please wait...